|
September 10, 2020
|
Neoleukin Therapeutics Announces Appointment of Martin Babler to Board of Directors
|
|
|
September 9, 2020
|
Neoleukin Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment Conference
|
|
|
August 12, 2020
|
Neoleukin Therapeutics Announces Second Quarter 2020 Financial Results & Provides Corporate Update
|
|
|
August 6, 2020
|
Neoleukin Therapeutics to Present at Canaccord Genuity 40th Annual Growth Conference
|
|
|
August 5, 2020
|
Neoleukin Therapeutics to Host Second Quarter 2020 Financial Results & Corporate Update Conference Call and Webcast on August 12, 2020
|
|
|
July 2, 2020
|
Neoleukin Therapeutics Announces Pricing of $76.2 Million Public Offering
|
|
|
July 1, 2020
|
Neoleukin Therapeutics Announces Proposed Public Offering
|
|
|
June 22, 2020
|
Neoleukin Therapeutics Presents Preclinical Data for NL-201 and De Novo Protein Design Technology at American Association for Cancer Research (AACR) Virtual Annual Meeting II
|
|
|
June 15, 2020
|
Neoleukin Therapeutics to Host Investor R&D Showcase Highlighting De Novo Protein Therapeutics
|
|
|
June 1, 2020
|
Neoleukin Therapeutics Announces Appointment of Erin Lavelle to Board of Directors
|
|
